ECRM_1170x120_8-1-17

the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act

NCPA attends signing of bipartisan opioid relief package

NCPA attends signing of bipartisan opioid relief package

WASHINGTON  – As President Trump signs H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, several National Community Pharmacists Association-supported provisions contained in the opioid package become law. NCPA chief executive officer B. Douglas Hoey and Karry La Violette, NCPA’s senior vice president of government affairs and director